As development of a phenotype resistant to oxidative and metabolic stress may be mediated by arsenic-induced translationally controlled tumor protein (TCTP), improved outcomes in cancer treatment could be obtained by using TCTP inhibitors [37]. Here, TPT1 is linked to cancer.